Regeneron: Antibody Cocktail Effective In Preventing COVID-19 Infection

Regeneron Pharmaceuticals Inc said on Tuesday its antibody cocktail was found effective in preventing COVID-19 in people exposed to those infected with the new coronavirus in an ongoing late stage trial.

The two-antibody cocktail, REGEN-COV, caused a 100% reduction in symptomatic infection and roughly 50% lower overall rates of infection, based on an early analysis of 400 participants in the trial who had a household member with COVID-19.

Check out the full story right here.